Targeting mGlu Receptors for Optimization of Antipsychotic Activity and Disease-Modifying Effect in Schizophrenia-Reference-Cited by-同舟云学术

Targeting mGlu Receptors for Optimization of Antipsychotic Activity and Disease-Modifying Effect in Schizophrenia

Published:2019-02-14 Issue: Volume:10 Page:
ISSN:1664-0640
Container-title:Frontiers in Psychiatry
language:
Short-container-title:Front. Psychiatry

Author:

Nicoletti Ferdinando,Orlando Rosamaria,Di Menna Luisa,Cannella Milena,Notartomaso Serena,Mascio Giada,Iacovelli Luisa,Matrisciano Francesco,Fazio Francesco,Caraci Filippo,Copani Agata,Battaglia Giuseppe,Bruno Valeria

Publisher

Frontiers Media SA

Subject

Psychiatry and Mental health

Reference116 articles.

1. The effect of antipsychotic treatment on cortical gray matter changes in schizophrenia: does the class matter? A meta-analysis and meta-regression of longitudinal magnetic resonance imaging studies;Vita;Biol Psychiatry,2015

2. mGluR5 hypofunction is integral to glutamatergic dysregulation in schizophrenia;Wang;Mol Psychiatry,2018

3. Metabotropic glutamate receptors: from the workbench to the bedside;Nicoletti;Neuropharmacology,2011

4. Unique signaling profiles of positive allosteric modulators of metabotropic glutamate receptor subtype 5 determine differences in in vivo activity;Rook;Biol Psychiatry,2013

5. Biased mGlu5-positive allosteric modulators provide in vivo efficacy without potentiating mGlu5 modulation of NMDAR currents;Rook;Neuron,2015

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular and micro-architectural mapping of abnormal gray matter developmental trajectories in psychosis;2023-12-11

2. Genome Sequencing of Consanguineous Family Implicates Ubiquitin-Specific Protease 53 (USP53) Variant in Psychosis/Schizophrenia: Wild-Type Expression in Murine Hippocampal CA 1–3 and Granular Dentate with AMPA Synapse Interactions;Genes;2023-10-09

3. Epigenetic regulation of metabotropic glutamate 2/3 receptors: Potential role for ultra-resistant schizophrenia?;Pharmacology Biochemistry and Behavior;2023-08

4. Oscillatory Deficits in the Sub-Chronic PCP Rat Model for Schizophrenia Are Reversed by mGlu5 Receptor-Positive Allosteric Modulators VU0409551 and VU0360172;Cells;2023-03-16

5. Understanding translational research in schizophrenia: A novel insight into animal models;Molecular Biology Reports;2023-01-24